Last $111.07 USD
Change Today +0.09 / 0.08%
Volume 4.0M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 11/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael D. Casey

Lead Independent Director, Chairman of Nominating, Governance & Compliance Committee, Member of Executive Committee and Member of Management Compensation & Development Committee, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 20 board members in 3 different organizations across 7 different industries.

See Board Relationships
68$874,681

Background*

Mr. Michael D. Casey, also known as Mike, has been a Consultant to the pharmaceutical industry since February 2002. Mr. Casey served as the President and Chief Executive Officer of Matrix Pharmaceutical Inc. from September 1997 to February 2002. He joined Matrix in October 1997 from Schein Pharmaceutical Inc. ("Schein"), a generic and ethical pharmaceutical company. He served as an Executive Vice President of Schein Pharmaceutical Inc. from November 1995 to December ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

1997-N/A
Former Chairman, Chief Executive Officer and President
2001-N/A
Director, Chairman of Governance Committee and Member of Nominating Committee
2001-N/A
Former Director, Chairman of Compensation Committee and Member of Nominating and Corporate Governance Committee
2002-2010
Former Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2002-Present
Lead Independent Director, Chairman of Nominating, Governance & Compliance Committee, Member of Executive Committee and Member of Management Compensation & Development Committee
2002-Present
Director
2004-2013
Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2004-2007
Former Director and Member of Compensation Committee
2006-2010
Former Chairman of the Board, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2010-Present
Director, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$142,500
Total Calculated Compensation$874,681
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $111.07 USD +0.09

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Flemming Ornskov M.D., MBA, MPHManaging Director, Chief Executive Officer and Director
Shire plc
$2.7M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.